Sponsor or institution
Clinical trials and research at Keylicon Biosciences INC
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $1.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Improving saRNA vaccine stability to ease cold storage for COVID-19 vaccines
Aimed at making saRNA coronavirus vaccines more stable at higher temperatures so it’s easier to store, ship, and use.
-
Long-acting GCase therapy for Gaucher disease using saRNA injections
A new injectable therapy aims to deliver the Gaucher disease enzyme GCase every three months using a self-amplifying RNA platform to reduce treatment burden.
-
Low-Dose Multivalent saRNA Influenza Vaccine for Safer, Faster Protection
A new low-dose self-amplifying RNA influenza vaccine that targets four flu antigens could offer quicker, stronger protection with fewer side effects.
-
Multivalent saRNA Lyme Vaccine for Broad Protection
A new RNA-based vaccine aims to protect people against multiple Lyme disease bacteria using a single low-dose shot.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.